Correction: Maternal immunoreactivity to herpes simplex virus 2 and risk of autism spectrum disorder in male offspring [mSphere, 2, 1, (2017) (e00016-17)] DOI:10.1128/mSphere.00016-17;Maternal immunoreactivity to herpes simplex virus 2 and risk of autism spectrum disorder in male offspring

mSphere

Volumn 2, Issue 1, 2017, Pages

  Mahic, Milada ^a,b   Mjaaland, Siri ^a,b   Bøvelstad, Hege Marie ^b   Gunnes, Nina ^b   Susser, Ezra ^a,c   Bresnahan, Michaeline ^a,c   Øyen, Anne Siri ^b,f   Levin, Bruce ^a   Che, Xiaoyu ^a   Hirtz, Deborah ^d,h   Reichborn Kjennerud, Ted ^b,e   Schjølberg, Synnve ^b   Roth, Christine ^b,f   Magnus, Per ^b   Stoltenberg, Camilla ^b,g   Surén, Pål ^b   Hornig, Mady ^a   Lipkin, W Ian ^a  

^a Columbia University ^*  (United States)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^e UNIVERSITY OF OSLO   (Norway)

^f LOVISENBERG DIAKONALE HOSPITAL   (Norway)

^g UNIVERSITY OF BERGEN   (Norway)

^h UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Autism; Birth cohort; Herpes simplex virus; Infection; Prenatal; Serology

Indexed keywords

EID: 85026392828     PISSN: None     EISSN: 23795042     Source Type: Journal    
DOI: 10.1128/mSphere.00154-17     Document Type: Erratum

References (69)

1. American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders, 5th ed. American Psychiatric Association, Washington, DC
2. Ozonoff S, Goodlin-Jones BL, Solomon M. 2005. Evidence-based assessment of autism spectrum disorders in children and adolescents. J Clin Child Adolesc Psychol 34:523-540. https://doi.org/10.1207/s15374424 jccp3403_8
3. Elsabbagh M, Divan G, Koh YJ, Kim YS, Kauchali S, Marcín C, Montiel-Nava C, Patel V, Paula CS, Wang C, Yasamy MT, Fombonne E. 2012. Global prevalence of autism and other pervasive developmental disorders. Autism Res 5:160-179. https://doi.org/10.1002/aur.239
4. Werling DM, Geschwind DH. 2013. Sex differences in autism spectrum disorders. Curr Opin Neurol 26:146-153. https://doi.org/10.1097/WCO .0b013e32835ee548
5. Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T, Miller J, Fedele A, Collins J, Smith K, Lotspeich L, Croen LA, Ozonoff S, Lajonchere C, Grether JK, Risch N. 2011. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 68:1095-1102. https://doi.org/10.1001/archgenpsychiatry .2011.76
6. Lyall K, Schmidt RJ, Hertz-Picciotto I. 2014. Maternal lifestyle and environmental risk factors for autism spectrum disorders. Int J Epidemiol 43:443-464. https://doi.org/10.1093/ije/dyt282
7. Brown AS. 2012. Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism. Dev Neurobiol 72:1272-1276. https://doi.org/10.1002/dneu.22024
8. Buka SL, Cannon TD, Torrey EF, Yolken RH, Collaborative Study Group on the Perinatal Origins of Severe Psychiatric Disorders. 2008. Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring. Biol Psychiatry 63:809-815. https://doi.org/10.1016/j.biopsych .2007.09.022
9. Matelski L, Van de Water J. 2016. Risk factors in autism: thinking outside the brain. J Autoimmun 67:1-7. https://doi.org/10.1016/j.jaut .2015.11.003
10. Patterson PH. 2002. Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness. Curr Opin Neurobiol 12:115-118
11. Estes ML, McAllister AK. 2015. Immune mediators in the brain and peripheral tissues in autism spectrum disorder. Nat Rev Neurosci 16: 469-486. https://doi.org/10.1038/nrn3978
12. Hornig M. 2013. The role of microbes and autoimmunity in the pathogenesis of neuropsychiatric illness. Curr Opin Rheumatol 25:488-795. https://doi.org/10.1097/BOR.0b013e32836208de
13. De Miranda J, Yaddanapudi K, Hornig M, Villar G, Serge R, Lipkin WI. 2010. Induction of toll-like receptor 3-mediated immunity during gestation inhibits cortical neurogenesis and causes behavioral disturbances. mBio 1:e00176-10. https://doi.org/10.1128/mBio.00176-10
14. Malkova NV, Yu CZ, Hsiao EY, Moore MJ, Patterson PH. 2012. Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. Brain Behav Immun 26:607-616. https:// doi.org/10.1016/j.bbi.2012.01.011
15. Shet A. 2011. Congenital and perinatal infections: throwing new light with an old TORCH. Indian J Pediatr 78:88-95. https://doi.org/10.1007/ s12098-010-0254-3
16. Neu N, Duchon J, Zachariah P. 2015. TORCH infections. Clin Perinatol 42:77-103. https://doi.org/10.1016/j.clp.2014.11.001
17. Chemla C, Villena I, Aubert D, Hornoy P, Dupouy D, Leroux B, Bory JP, Pinon JM. 2002. Preconception seroconversion and maternal seronegativity at delivery do not rule out the risk of congenital toxoplasmosis. Clin Diagn Lab Immunol 9:489-490. https://doi.org/10.1128/CDLI.9.2 .489-490.2002
18. Dollfus H, Dureau P, Hennequin C, Uteza Y, Bron A, Dufier JL. 1998. Congenital toxoplasma chorioretinitis transmitted by preconceptionally immune women. Br J Ophthalmol 82:1444-1445
19. Robert-Gangneux F, Yera H, D'Herve D, Guiguen C. 2009. Congenital toxoplasmosis after a preconceptional or periconceptional maternal infection. Pediatr Infect Dis J 28:660-661. https://doi.org/10.1097/INF .0b013e3181966020
20. Vogel N, Kirisits M, Michael E, Bach H, Hostetter M, Boyer K, Simpson R, Holfels E, Hopkins J, Mack D, Mets MB, Swisher CN, Patel D, Roizen N, Stein L, Stein M, Withers S, Mui E, Egwuagu C, Remington J, Dorfman R, McLeod R. 1996. Congenital toxoplasmosis transmitted from an immunologically competent mother infected before conception. Clin Infect Dis 23:1055-1060
21. Landais I, Nelson JA. 2013. Functional genomics approaches to understand cytomegalovirus replication, latency and pathogenesis. Curr Opin Virol 3:408-415. https://doi.org/10.1016/j.coviro.2013.06.002
22. Roizman B, Whitley RJ. 2013. An inquiry into the molecular basis of HSV latency and reactivation. Annu Rev Microbiol 67:355-374. https://doi .org/10.1146/annurev-micro-092412-155654
23. Atladóttir Hó, Henriksen TB, Schendel DE, Parner ET. 2012. Autism after infection, febrile episodes, and antibiotic use during pregnancy: an exploratory study. Pediatrics 130:e1447-e1454. https://doi.org/10.1542/ peds.2012-1107
24. Atladóttir HO, Thorsen P, Østergaard L, Schendel DE, Lemcke S, Abdallah M, Parner ET. 2010. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 40: 1423-1430. https://doi.org/10.1007/s10803-010-1006-y
25. Gentile I, Zappulo E, Bonavolta R, Maresca R, Messana T, Buonomo AR, Portella G, Sorrentino R, Settimi A, Pascotto A, Borgia G, Bravaccio C. 2014. Prevalence and titre of antibodies to cytomegalovirus and Epstein-Barr virus in patients with autism spectrum disorder. In Vivo 28:621-626
26. Gentile I, Zappulo E, Bonavolta R, Maresca R, Riccio MP, Buonomo AR, Portella G, Vallefuoco L, Settimi A, Pascotto A, Borgia G, Bravaccio C. 2014. Prevalence of herpes simplex virus 1 and 2 antibodies in patients with autism spectrum disorders. In Vivo 28:667-671
27. Olsen AO, Orstavik I, Dillner J, Vestergaard BF, Magnus P. 1998. Herpes simplex virus and human papillomavirus in a population-based casecontrol study of cervical intraepithelial neoplasia grade II-III. APMIS 106:417-424
28. Eskild A, Jeansson S, Stray-Pedersen B, Jenum PA. 2002. Herpes simplex virus type-2 infection in pregnancy: no risk of fetal death: results from a nested case-control study within 35,940 women. BJOG 109:1030-1035
29. Eskild A, Jenum PA, Bruu AL. 2005. Maternal antibodies against cytomegalovirus in pregnancy and the risk of fetal death and low birth weight. Acta Obstet Gynecol Scand 84:1035-1041. https://doi.org/10 .1111/j.0001-6349.2005.00796.x
30. Jenum PA, Stray-Pedersen B, Melby KK, Kapperud G, Whitelaw A, Eskild A, Eng J. 1998. Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol 36:2900-2906
31. Yasuhara M, Tamaki H, Iyama S, Yamaguchi Y, Tachi J, Amino N. 1992. Reciprocal changes in serum levels of immunoglobulins (IgG, IgA, IgM) and complements (C3, C4) in normal pregnancy and after delivery. J Clin Lab Immunol 38:137-141
32. Amino N, Tanizawa O, Miyai K, Tanaka F, Hayashi C, Kawashima M, Ichihara K. 1978. Changes of serum immunoglobulins IgG, IgA, IgM, and IgE during pregnancy. Obstet Gynecol 52:415-420
33. Miller EC, Abel W. 1984. Changes in the immunoglobulins IgG, IgA and IgM in pregnancy and the puerperium. Zentralbl Gynakol 106: 1084-1091. (In German.)
34. Abel J, Conklin J, Hunter S, Empey R, Tyler E, Christensen A, Talcott K, Ballas Z, Santillan M, Santillan D. 2013. Defining normal IgG changes throughout pregnancy. Proc Obstet Gynecol 3:Article 8
35. Enright AM, Prober CG. 2004. Herpesviridae infections in newborns: varicella zoster virus, herpes simplex virus, and cytomegalovirus. Pediatr Clin North Am 51:889-908. https://doi.org/10.1016/j.pcl.2004.03.005
36. Sacks SL, Griffiths PD, Corey L, Cohen C, Cunningham A, Dusheiko GM, Self S, Spruance S, Stanberry LR, Wald A, Whitley RJ. 2004. HSV shedding. Antiviral Res 63(Suppl 1):S19-S26. https://doi.org/10.1016/j.antiviral .2004.06.004
37. Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L. 2003. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 289:203-209. https://doi.org/ 10.1001/jama.289.2.203
38. Thompson C, Whitley R. 2011. Neonatal herpes simplex virus infections: where are we now? Adv Exp Med Biol 697:221-230. https://doi.org/10 .1007/978-1-4419-7185-2_15
39. Avgil M, Ornoy A. 2006. Herpes simplex virus and Epstein-Barr virus infections in pregnancy: consequences of neonatal or intrauterine infection. Reprod Toxicol 21:436-445. https://doi.org/10.1016/j.reprotox .2004.11.014
40. Whitley RJ, Kimberlin DW, Roizman B. 1998. Herpes simplex viruses. Clin Infect Dis 26:541-553
41. Atladóttir HO, Pedersen MG, Thorsen P, Mortensen PB, Deleuran B, Eaton WW, Parner ET. 2009. Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics 124:687-694. https:// doi.org/10.1542/peds.2008-2445
42. Croen LA, Grether JK, Yoshida CK, Odouli R, Van de Water J. 2005. Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch Pediatr Adolesc Med 159:151-157. https://doi.org/10.1001/archpedi.159.2.151
43. Kohane IS, McMurry A, Weber G, MacFadden D, Rappaport L, Kunkel L, Bickel J, Wattanasin N, Spence S, Murphy S, Churchill S. 2012. The co-morbidity burden of children and young adults with autism spectrum disorders. PLoS One 7:e33224. https://doi.org/10.1371/journal .pone.0033224
44. Brimberg L, Sadiq A, Gregersen PK, Diamond B. 2013. Brain-reactive IgG correlates with autoimmunity in mothers of a child with an autism spectrum disorder. Mol Psychiatry 18:1171-1177. https://doi.org/10 .1038/mp.2013.101
45. Martin LA, Ashwood P, Braunschweig D, Cabanlit M, Van de Water J, Amaral DG. 2008. Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav Immun 22:806-816. https://doi.org/10.1016/j.bbi.2007.12.007
46. Johnston C, Corey L. 2016. Current concepts for genital herpes simplex virus infection: diagnostics and pathogenesis of genital tract shedding. Clin Microbiol Rev 29:149-161. https://doi.org/10.1128/CMR.00043-15
47. Johnston C, Zhu J, Jing L, Laing KJ, McClurkan CM, Klock A, Diem K, Jin L, Stanaway J, Tronstein E, Kwok WW, Huang ML, Selke S, Fong Y, Magaret A, Koelle DM, Wald A, Corey L. 2014. Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection. J Virol 88:4921-4931. https://doi.org/10.1128/JVI.03285-13
48. Wald A, Zeh J, Selke S, Warren T, Ryncarz AJ, Ashley R, Krieger JN, Corey L. 2000. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 342:844-850. https:// doi.org/10.1056/NEJM200003233421203
49. Fernandez S, Gillgrass A, Kaushic C. 2007. Differential responses of murine vaginal and uterine epithelial cells prior to and following herpes simplex virus type 2 (HSV-2) infection. Am J Reprod Immunol 57: 367-377. https://doi.org/10.1111/j.1600-0897.2007.00482.x
50. Nason MC, Patel EU, Kirkpatrick AR, Prodger JL, Shahabi K, Tobian AA, Gianella S, Kalibbala S, Ssebbowa P, Kaul R, Gray RH, Quinn TC, Serwadda D, Reynolds SJ, Redd AD. 2016. Immunological signaling during herpes simplex virus-2 and cytomegalovirus vaginal shedding after initiation of antiretroviral treatment. Open Forum Infect Dis 3:ofw073. https://doi .org/10.1093/ofid/ofw073
51. Chow SS, Craig ME, Jones CA, Hall B, Catteau J, Lloyd AR, Rawlinson WD. 2008. Differences in amniotic fluid and maternal serum cytokine levels in early midtrimester women without evidence of infection. Cytokine 44: 78-84. https://doi.org/10.1016/j.cyto.2008.06.009
52. Dammann O, Leviton A. 1997. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 42:1-8. https:// doi.org/10.1203/00006450-199707000-00001
53. Potter JA, Garg M, Girard S, Abrahams VM. 2015. Viral single stranded RNA induces a trophoblast pro-inflammatory and antiviral response in a TLR8-dependent and-independent manner. Biol Reprod 92:17. https:// doi.org/10.1095/biolreprod.114.124032
54. Zaretsky MV, Alexander JM, Byrd W, Bawdon RE. 2004. Transfer of inflammatory cytokines across the placenta. Obstet Gynecol 103: 546-550. https://doi.org/10.1097/01.AOG.0000114980.40445.83
55. Hsiao EY, Patterson PH. 2011. Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain Behav Immun 25:604-615. https://doi.org/10.1016/j.bbi.2010.12.017
56. Malaeb S, Dammann O. 2009. Fetal inflammatory response and brain injury in the preterm newborn. J Child Neurol 24:1119-1126. https://doi .org/10.1177/0883073809338066
57. McAdams RM, Juul SE. 2012. The role of cytokines and inflammatory cells in perinatal brain injury. Neurol Res Int 2012:561494. https://doi.org/10 .1155/2012/561494
58. Abdallah MW, Larsen N, Grove J, Nørgaard-Pedersen B, Thorsen P, Mortensen EL, Hougaard DM. 2013. Amniotic fluid inflammatory cytokines: potential markers of immunologic dysfunction in autism spectrum disorders. World J Biol Psychiatry 14:528-538. https://doi.org/10 .3109/15622975.2011.639803
59. Steeb H, Ramsey JM, Guest PC, Stocki P, Cooper JD, Rahmoune H, Ingudomnukul E, Auyeung B, Ruta L, Baron-Cohen S, Bahn S. 2014. Serum proteomic analysis identifies sex-specific differences in lipid metabolism and inflammation profiles in adults diagnosed with Asperger syndrome. Mol Autism 5:4. https://doi.org/10.1186/2040-2392-5-4
60. Challis J, Newnham J, Petraglia F, Yeganegi M, Bocking A. 2013. Fetal sex and preterm birth. Placenta 34:95-99. https://doi.org/10.1016/j.placenta .2012.11.007
61. Yeganegi M, Watson CS, Martins A, Kim SO, Reid G, Challis JR, Bocking AD. 2009. Effect of Lactobacillus rhamnosus GR-1 supernatant and fetal sex on lipopolysaccharide-induced cytokine and prostaglandinregulating enzymes in human placental trophoblast cells: implications for treatment of bacterial vaginosis and prevention of preterm labor. Am J Obstet Gynecol 200:532.e1-532.e8. https://doi.org/10.1016/j.ajog .2008.12.032
62. Brettell R, Yeh PS, Impey LW. 2008. Examination of the association between male gender and preterm delivery. Eur J Obstet Gynecol Reprod Biol 141:123-126. https://doi.org/10.1016/j.ejogrb.2008.07.030
63. McGregor JA, Leff M, Orleans M, Baron A. 1992. Fetal gender differences in preterm birth: findings in a North American cohort. Am J Perinatol 9:43-48. https://doi.org/10.1055/s-2007-994668
64. Meyer U, Nyffeler M, Engler A, Urwyler A, Schedlowski M, Knuesel I, Yee BK, Feldon J. 2006. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 26:4752-4762. https://doi.org/10.1523/JNEUROSCI.0099-06.2006
65. Goines PE, Croen LA, Braunschweig D, Yoshida CK, Grether J, Hansen R, Kharrazi M, Ashwood P, Van de Water J. 2011. Increased midgestational IFN-gamma, IL-4 and IL-5 in women bearing a child with autism: a case-control study. Mol Autism 2:13. https://doi.org/10.1186/2040-2392-2-13
66. Patterson PH. 2011. Maternal infection and immune involvement in autism. Trends Mol Med 17:389-394. https://doi.org/10.1016/j.molmed .2011.03.001
67. Jones KL, Croen LA, Yoshida CK, Heuer L, Hansen R, Zerbo O, DeLorenze GN, Kharrazi M, Yolken R, Ashwood P, Van de Water J. 2017. Autism with intellectual disability is associated with increased levels of maternal cytokines and chemokines during gestation. Mol Psychiatry 22:273-279. https://doi.org/10.1038/mp.2016.77
68. Magnus P, Birke C, Vejrup K, Haugan A, Alsaker E, Daltveit AK, Handal M, Haugen M, Høiseth G, Knudsen GP, Paltiel L, Schreuder P, Tambs K, Vold L, Stoltenberg C. 2016. Cohort profile update: the Norwegian Mother and Child Cohort Study (MoBa). Int J Epidemiol 45:382-388. https://doi .org/10.1093/ije/dyw029
69. Stoltenberg C, Schjølberg S, Bresnahan M, Hornig M, Hirtz D, Dahl C, Lie KK, Reichborn-Kjennerud T, Schreuder P, Alsaker E, Øyen AS, Magnus P, Surén P, Susser E, Lipkin WI, ABC Study Group. 2010. The Autism Birth Cohort: a paradigm for gene-environment-timing research. Mol Psychiatry 15:676-680. https://doi.org/10.1038/mp.2009.143